These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34091531)

  • 1. Does Loss of Immunohistochemical Expression of Glypican 3 in Oral Squamous Cell Carcinoma Play a Role in the Wnt/β-catenin Signaling Pathway?
    Jot K; Urs AB; Kumar P
    Appl Immunohistochem Mol Morphol; 2021 Oct; 29(9):693-699. PubMed ID: 34091531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glypican-1, -3, -5 (GPC1, GPC3, GPC5) and Hedgehog Pathway Expression in Oral Squamous Cell Carcinoma.
    Schlaepfer Sales CB; Guimarães VSN; Valverde LF; Dias RB; Freitas RD; Siquara da Rocha LO; Coelho de Miranda M; Vilas Bôas DS; Gonçalves Agra IM; Dos Santos JN; Gurgel Rocha CA
    Appl Immunohistochem Mol Morphol; 2021 May-Jun 01; 29(5):345-351. PubMed ID: 33512817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin inhibits lung squamous cell carcinoma growth by downregulating glypican-3/Wnt/β-catenin signaling and autophagy.
    Bi Y; Jiang Y; Li X; Hou G; Li K
    J Cancer Res Clin Oncol; 2021 Feb; 147(2):499-505. PubMed ID: 33225417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glypican-3 promotes cell proliferation and tumorigenesis through up-regulation of β-catenin expression in lung squamous cell carcinoma.
    Wang D; Gao Y; Zhang Y; Wang L; Chen G
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31160489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of Nav1.5 inhibits cell proliferation, migration and invasion via Wnt/β-catenin signaling pathway in oral squamous cell carcinoma.
    Xu X; Dai Y; Feng L; Zhang H; Hu Y; Xu L; Zhu X; Jiang Y
    Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):527-535. PubMed ID: 32400862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RELA promotes the progression of oral squamous cell carcinoma via TFAP2A-Wnt/β-catenin signaling.
    Yang K; Zhao J; Liu S; Man S
    Mol Carcinog; 2023 May; 62(5):641-651. PubMed ID: 36789977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity-related long noncoding RNA WDFY3-AS2 inhibited cell proliferation and metastasis through Wnt/β-catenin signaling in oral squamous cell carcinoma.
    Lin X; Ding JM; Zheng XZ; Chen JG
    Arch Oral Biol; 2023 Mar; 147():105625. PubMed ID: 36657277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of Differential Expression of β-Catenin in Oral Carcinoma.
    Moles MA; Montoya JA; Salvago MD; Ávila IR; Campillo JJ; Bravo M
    Anticancer Res; 2016 Apr; 36(4):1599-604. PubMed ID: 27069136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA MINCR activates Wnt/β-catenin signals to promote cell proliferation and migration in oral squamous cell carcinoma.
    Lyu Q; Jin L; Yang X; Zhang F
    Pathol Res Pract; 2019 May; 215(5):924-930. PubMed ID: 30777615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher expression of WNT5A protein in oral squamous cell carcinoma compared with dysplasia and oral mucosa with a normal appearance.
    Prgomet Z; Andersson T; Lindberg P
    Eur J Oral Sci; 2017 Aug; 125(4):237-246. PubMed ID: 28603941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of β-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma.
    Li L; Liu HC; Wang C; Liu X; Hu FC; Xie N; Lü L; Chen X; Huang HZ
    Biomed Res Int; 2016; 2016():5378567. PubMed ID: 27529071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternation of β-catenin and CD44s Immunoexpression in Different Histopathological Grades of Oral Squamous Cell Carcinoma.
    Zargaran M
    Asian Pac J Cancer Prev; 2020 May; 21(5):1181-1185. PubMed ID: 32458620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WNT3 promotes chemoresistance to 5-Fluorouracil in oral squamous cell carcinoma via activating the canonical β-catenin pathway.
    Zhang X; Sun K; Gan R; Yan Y; Zhang C; Zheng D; Lu Y
    BMC Cancer; 2024 May; 24(1):564. PubMed ID: 38711026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
    Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
    Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC00941 promotes oral squamous cell carcinoma progression via activating CAPRIN2 and canonical WNT/β-catenin signaling pathway.
    Ai Y; Wu S; Zou C; Wei H
    J Cell Mol Med; 2020 Sep; 24(18):10512-10524. PubMed ID: 32691935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway.
    Yu T; Liu K; Wu Y; Fan J; Chen J; Li C; Yang Q; Wang Z
    Oncogene; 2014 Oct; 33(42):5017-27. PubMed ID: 24141785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt/β-catenin signaling pathway participates in the effect of miR-626 on oral squamous cell carcinoma by targeting RASSF4.
    Cui SH; Hu XD; Yan Y
    J Oral Pathol Med; 2021 Nov; 50(10):1005-1017. PubMed ID: 34121238
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Huang C; Wang L; Song H; Wu C
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3037-3042. PubMed ID: 31342798
    [No Abstract]   [Full Text] [Related]  

  • 20. Both glypican-3/Wnt/β-catenin signaling pathway and autophagy contributed to the inhibitory effect of curcumin on hepatocellular carcinoma.
    Hu P; Ke C; Guo X; Ren P; Tong Y; Luo S; He Y; Wei Z; Cheng B; Li R; Luo J; Meng Z
    Dig Liver Dis; 2019 Jan; 51(1):120-126. PubMed ID: 30001951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.